Radioimmunoguided surgery has been attempted using intraoperative
tumor detection with radiolabeled
monoclonal antibody (mAb). Directly radiolabeled mAb showed poor
tumor imaging due to high blood-pool radioactivity. In 1991, three-step immunoscintigraphy of the
avidin-
biotin system was reported. This three-step method improved
tumor imaging because it reduced background radioactivity. Although there were some problems such as a human anti-mouse response and anti-
avidin response, the three-step clinical protocol was performed in various
cancer patients, and many good results (the
tumor detection rate was about 85%) were reported. On the other hand, recent major trials on
tumor localization and sentinel lymph node detection have been performed using FDG-PET. However, radioimmunoscintigraphy has the major advantage of simultaneous
tumor diagnosis and treatment. In the near future, radioimmunoscintigraphy may become a useful diagnostic method with anticancer effects when its adverse effects are ameliorated by the application of gene technology.